U2AF1 and ZRSF2 rarely co‐occur and are considered mutually exclusive in bone marrow tumours [10], suggesting that either both variants may have occurred in different clones during the clonal evolution of the disease, or spliceosomal regulation in cells carrying both mutations has been severely altered. Here, U2AF1 is linked to neoplasm.